#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pustular psoriasis HER2 mutant non-small cell lung cancer Hepatitis B Intracranial germ cell tumour Pyruvate kinase deficiency anaemia Focal segmental glomerulosclerosis Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Fallopian tube cancer Subarachnoid haemorrhage Oesophageal squamous cell carcinoma stage III Systemic mastocytosis Basal cell naevus syndrome Fabry's disease Antiphospholipid antibodies Ehlers-Danlos syndrome More trials…

    Learn about Rare Diseases

    Progressive multifocal leukoencephalopathy – Basic Information Soft tissue sarcoma Fabry’s disease – Treatment Haemophilia A without inhibitors – Basic Information Ocular melanoma – Life with Disease Richter’s syndrome – Diagnostics Encephalitis autoimmune – Treatment Cystic fibrosis lung Pleural mesothelioma malignant – Treatment Lysosomal storage disorder More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Valoctocogene Roxaparvovec Pivekimab Sunirine Mocravimod Larotrectinib Sulfate Human Coagulation Factor X Dinutuximab Beta Fitusiran Sodium Zirconium Cyclosilicate TEV-53408 Anhydrous Docetaxel Nilotinib Bi-1808 Icosapent Ethyl Ofloxacin Hydrochloride Molidustat Sodium Aficamten HYDROGEN Mitotane Rbl035.2 Potato Starch More therapies…

    Learn about Your Condition

    Thalassaemia Retinopathy proliferative Bacterial vaginosis Liposarcoma recurrent Hepatotoxicity Loeys-Dietz syndrome Candida infection Oedema Pulmonary alveolar haemorrhage Haemodialysis Ankylosing spondylitis Retinal neovascularisation Lymphocytic leukaemia Micrographic skin surgery Agitation postoperative More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Relugolix and Radiation Therapy for Patients with Intermediate Risk Prostate Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Relugolix
    Italy

  • Study of IOMX-0675 alone or combined with pembrolizumab for patients with previously treated advanced or metastatic solid tumors

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Pembrolizumab
    Spain

  • A study of orismilast alone or combined with semaglutide for weight management in people with obesity

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Orismilast
    • Semaglutide
    Denmark

  • Study on Thiopental Sodium Dose During Electroconvulsive Therapy for Patients with Major Depressive Disorder

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Thiopental Sodium
    Sweden

  • Study of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Panitumumab
    • Sotorasib
    • Fluorouracil
    France Germany Italy Spain

  • Study of Cabozantinib for Patients with Non-Small Cell Lung Cancer and MET Deregulation

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Cabozantinib
    Italy
Previous Page
1 … 799 800 801 802 803 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!